Drug Shortage Report for OCTREOSCAN
| Report ID | 222588 |
| Drug Identification Number | 02329271 |
| Brand name | OCTREOSCAN |
| Common or Proper name | Kit for the preparation of Indium In 111 Pentetreotide |
| Company Name | CURIUM CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PENTETREOTIDE INDIUM IN 111 CHLORIDE |
| Strength(s) | 10MCG 111MBq |
| Dosage form(s) | POWDER FOR SOLUTION KIT SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 ml |
| ATC code | V09IB |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-03-18 |
| Estimated end date | 2024-03-31 |
| Actual end date | 2024-04-08 |
| Shortage status | Resolved |
| Updated date | 2024-04-09 |
| Company comments | The most recent lot of Indium In-111 raw material used in the production of Octreoscan did not meet quality specifications. As a result, product will not be available for shipment Sunday, Mar 17 and Monday, Mar 18, & Mar 24 and Mar 25. The next lot is scheduled to release Sunday, Mar 31. We apologize for any inconvenience caused by this issue. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-04-09 | French | Compare |
| v6 | 2024-04-09 | English | Compare |
| v5 | 2024-03-25 | French | Compare |
| v4 | 2024-03-25 | English | Compare |
| v3 | 2024-03-19 | English | Compare |
| v2 | 2024-03-18 | French | Compare |
| v1 | 2024-03-18 | English | Compare |
Showing 1 to 7 of 7